United Therapeutics Corp (NASDAQ:UTHR)

183.69
Delayed Data
As of May 22
 +1.08 / +0.59%
Today’s Change
84.63
Today|||52-Week Range
190.29
+41.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues322.8M330.0M346.4M327.5M
 
 
 
 
 
Cost of Goods Sold31.1M32.7M6.8M12.4M
 
 
 
 
 
Depreciation And Amortization7.6M8.1M8.9M8.3M
 
 
 
 
 
 
Operating ExpensesGross Income284.1M289.1M330.6M306.7M
 
 
 
 
 
General Expenses107.8M321.4M152.0M321.6M
 
 
 
 
 
Research And Development39.7M118.9M71.5M110.2M
 
 
 
 
 
Total Operating Expenses146.5M362.2M167.8M342.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income176.3M-32.2M178.6M-14.8M
 
 
 
 
 
Extraordinary Credit1.1M0.000.000.00
 
 
Interest Expense On Debt4.7M4.7M3.5M2.1M
 
 
 
 
 
Other Expenses-800.0K1.1M-285.0K93.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income173.0M-35.8M174.8M-16.8M
 
 
 
 
 
Income Taxes-61.2M-10.6M-58.8M-151.0K
 
 
 
 
 
Net Income111.9M-25.2M115.9M-16.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.6M47.3M47.4M46.7M
 
 
 
 
 
Shares To Calculate EPS Diluted53.3M47.3M53.5M46.7M
 
 
 
 
 
 
Earnings Per ShareEPS$2.10-$0.53$2.17-$0.36
 
 
 
 
 
EPS Diluted$2.10-$0.53$2.17-$0.36
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account